Hidden Cost of Rheumatoid Arthritis (RA): Estimating Cost of Comorbid Cardiovascular Disease and Depression Among Patients with RA
Open Access
- 17 February 2009
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 36 (4), 743-752
- https://doi.org/10.3899/jrheum.080670
Abstract
Objective.To examine resource utilization and direct healthcare cost associated with comorbid cardiovascular disease (CVD) and depression among patients with prevalent rheumatoid arthritis (RA) based on analyses of retrospective healthcare claims data.Methods.The index date was set as the first observed claim with an RA diagnosis. Patients were required to be ≥ 18 years of age, to have received RA-related treatment during the pre-index period, and to have 12-month pre- and post-index data. Based on pre-index utilization, patients were classified into 4 diagnosis groups: RA alone, RA + CVD, RA + depression, and RA + CVD + depression. Analyses focused on annual differences in costs between patients with RA alone and those with CVD and/or depression. A generalized linear model was applied to control for demographic and clinical characteristics and to estimate cohort-specific adjusted mean annual healthcare cost.Results.Of 10,298 patients, 8,916 had RA alone (86.6%), 608 had RA + CVD (5.9%), 716 had RA + depression (7.0%), and 58 had RA + CVD + depression (0.5%). All patients with CVD and/or depression incurred significantly higher followup costs compared with patients with RA alone. Adjusted annual mean healthcare costs were highest for RA + CVD (US$14,145), followed by RA + CVD + depression ($13,513), RA + depression ($12,225), and RA alone ($11,404). Although patients with CVD and/or depression had a greater rate of RA-related hospitalization, adjusted RA-related healthcare costs did not reflect any statistically significant differences as compared to the RA-alone cohort.Conclusion.A significant proportion (13.4%) of patients with prevalent RA have comorbid CVD and/or depression. The presence of these conditions significantly affects annual healthcare costs as well as specific RA-related utilization patterns.This publication has 21 references indexed in Scilit:
- Atherosclerosis and inflammation: insights from rheumatoid arthritisClinical Rheumatology, 2007
- Treatment of rheumatoid arthritisAmerican Journal of Health-System Pharmacy, 2006
- Depression in rheumatoid arthritis—underscoring the problemRheumatology, 2006
- Cardiovascular disease in rheumatoid arthritisCurrent Opinion in Rheumatology, 2006
- Depression in rheumatoid arthritis patients: demographic, clinical, and psychological predictorsJournal of Psychosomatic Research, 2006
- The Impact of Rheumatoid Arthritis on Medical Expenditures, Absenteeism, and Short-Term Disability BenefitsJournal of Occupational and Environmental Medicine, 2006
- Increased coronary‐artery atherosclerosis in rheumatoid arthritis: Relationship to disease duration and cardiovascular risk factorsArthritis & Rheumatism, 2005
- Epidemiology and burden of illness of rheumatoid arthritisPharmacoEconomics, 2004
- Co-morbidity in rheumatoid arthritisBest Practice & Research Clinical Rheumatology, 2003
- Depression and depressive symptoms in rheumatoid arthritis patients: an analysis of their occurrence and determinants.Rheumatology, 1998